Introduction. The aim of the study was to assess the risk of surgery after initial conservative treatment of rectosigmoid endometriosis in relation to demographic data. Material and methods. The study was conducted on the tertiary endometriosis referral unit, Aarhus University Hospital. Medical records, from patients seen from January 2009 onwards with a diagnosis of rectosigmoid endometriosis and more than 6 months' follow up were audited. Demographic data, results of magnetic resonance imaging and time to secondary surgery for rectosigmoid endometriosis were registered. Results. Data on 238 patients diagnosed with rectosigmoid endometriosis were included. In all, 78 (32.8%) patients had primary surgery, 27 (11.3%) had secondary surgery and 133 (55.9%) continued conservative treatment throughout the observation period. Patients who underwent primary or secondary surgery were younger than patients continuing conservative treatment. Conclusions. In a tertiary referral center where about half of patients with rectosigmoid endometriosis were scheduled for conservative treatment, more than 80% of these avoided surgery.
Introduction
Endometriosis is defined by ectopic presence of endometrium-like tissue (1) . The prevalence may be up to 10% among fertile women and the disease is a major cause of pelvic pain and reduced quality of life (2, 3) .
Deeply infiltrating endometriosis (DIE) is a severe form of the disease. This phenotype is defined by lesions invading more than 5 mm below the peritoneal surface (4) . DIE can invade the rectosigmoid wall (rectosigmoid
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A cohort of 238 patients with rectosigmoid endometriosis was followed. About half of the patients could be treated conservatively and more than 80% of these avoided later surgery. Median follow up was 22 months. endometriosis), causing symptoms such as dyspareunia and dyschezia, in addition to chronic pelvic pain (5) .
Rectosigmoid endometriosis may cause obstruction, and DIE with ureter stenosis is also seen. Such cases represent absolute indications for surgery, whereas pain represents a more relative indication where treatment can be surgical or medical.
Surgery for rectosigmoid endometriosis is complex, with a high risk of short-term complications (anastomotic leakage, ureteral injury). However, a recent study from our group showed a favorable long-term outcome (6) . Medical treatment with potential for long-term use should be the primary approach, provided that sufficient pain relief is achieved without unacceptable adverse effects. Such treatment may involve continuous oral contraceptives, the levonorgestrel-intrauterine device or oral gestagens.
Recent papers have provided detailed data on the longterm consequences of surgery for rectosigmoid endometriosis (6) (7) (8) . Less information is available on conservative medical treatment (9, 10) , and data on the need for bowel surgery at a later stage seem to be missing.
The aim of the present study was therefore to assess the risk of surgery after initial conservative treatment of rectosigmoid endometriosis in relation to demographic data.
Material and methods
This cohort study was conducted at the Department of Obstetrics and Gynecology, Aarhus University Hospital, which is one of two tertiary referral centers for endometriosis in Denmark. According to rules by the Danish Health Authority, treatment of advanced endometriosis is not allowed outside these two centers. Our team consisted of four doctors subspecialized in endometriosis.
Surgery for rectosigmoid endometriosis was restricted to cases with aggravating pain despite acceptable medical treatment, which included continuous oral contraceptives, the levonorgestrel-intrauterine device or oral gestagens. Conservatively treated patients with rectosigmoid endometriosis were monitored with at least one annual clinical outpatient visit. Women without a wish to conceive were advised to continue medical treatment until menopause.
In April 2013 a list of patients with a diagnosis of endometriosis affecting the rectosigmoid, vagina or the rectovaginal septum was drawn from the electronic patient record system according to ICD10 codes for DIE (DN-804, -804A, -804B, -804C, -805, -805A, -805B, -805C).
Records from patients diagnosed with rectosigmoid endometriosis from 1 January 2009 onwards with a minimum of 6 months' follow up (>182 days) were audited by the first author. Inclusion criteria were rectosigmoid endometriosis verified by transvaginal ultrasonography and/or magnetic resonance imaging (MRI). All MRI investigations were analyzed by the same subspecialized radiologist. Primary surgery was defined as referral for laparoscopic rectosigmoid resection within 6 months (182 days) of the first outpatient visit, irrespective of any previous surgery. Continued conservative treatment was defined as a minimum of 6 months of medical therapy. If patients, initially scheduled for continued conservative treatment, later underwent surgery (secondary surgery), time to secondary surgery was calculated as the timespan from the date of the first visit in the department to the date of the operation. During continued conservative treatment patients had regular follow up with the possibility to contact to the center. Data collected included demographic information, date of birth, weight and height, previous operations for endometriosis (number), oophorectomy status, current medical treatment (at the time of audit), and results of MRI findings with respect to location(s) of endometriosis.
Statistical analysis
Data were entered directly into Microsoft â EXCEL (Microsoft Corp, Redmond, WA, USA) and transferred to STATA â IC/13.1 (StataCorp., College Station, TX, USA) for statistical analysis. Weight and height was imputed when missing (weight n = 68, height n = 70) by assigning an average weight in four age-categories and height in four weight-categories. No attempt was made to impute missing information about hormonal treatment (n = 31). Differences in continuous variables were analyzed using Student's t-test for normally distributed data. Differences between categorical variables were analyzed using the chi-square test or Fisher's exact test where appropriate. Missing values were excluded from analysis. Time-to-event analysis (Kaplan-Meier) was used to analyze and visualize time to secondary surgery. Median with interquartile range (25/75 percentiles) was used to describe statistics for the time-to-event analysis. Differences were considered of statistical significance if p < 0.05. identified. In all, 78 (32.8%) patients had primary surgery, and 27 (11.3%) had secondary surgery. Thus, 133 (55.9%) patients had continued conservative treatment throughout the observation period ( Figure 1) .
Demographic data are presented in Table 1 . Patients receiving primary and secondary surgery were younger than patients receiving continued conservative treatment. No differences were found regarding body mass index, medical treatment at the time of follow up, oophorectomy status or previous surgery for endometriosis. Table 2 shows the distribution of endometriosis according to MRI. An MRI examination was available for analysis for 75 of the 78 patients referred for primary surgery, 111 of the 133 patients who continued conservative treatment, and 26 of the 27 patients undergoing secondary surgery. Patients undergoing primary surgery more often had an MRI examination for analysis compared with patients on continued conservative treatment. There were no differences between patients who had and those who did not have MRI as regards the parameters in Table 1 .
No differences were observed between the groups in number of rectosigmoid nodules, distance from the anal verge or the occurrence of endometriomas and adenomyosis.
Eleven (8.3%) of the patients receiving continued conservative treatment had infiltration in the rectosigmoid wall diagnosed by transvaginal ultrasonography only.
Time to secondary surgery was evaluated by KaplanMeier analysis (Figure 2 ).
In all, 160 patients were followed for a total of 3944.9 months. With a median follow up of 22.0 months (13.8-35.3), 27 (16.9%) patients needed secondary surgery. Median time to secondary surgery was 17.6 months (13.7-31.4). The longest follow up was 53.9 months.
All patients undergoing secondary surgery presented with pain. Three of these patients also had obstruction. One of these patients had total bowel obstruction and underwent acute surgery at a gastrointestinal unit.
Another had partial bowel obstruction and was scheduled for subacute surgery in our department. Ureter stenosis with hydronephrosis was seen in one patient. These three cases developed during in vitro fertilization treatment.
Discussion
In this study we describe a cohort of women with rectosigmoid endometriosis. In our setting, 67% of 238 patients with rectosigmoid endometriosis verified by imaging were scheduled for primary conservative treatment. Of these 160 patients treated conservatively, 27 (17%) were eventually referred for secondary surgery within a median follow up of 22 months. Median time to secondary surgery was 18 months. More than 80% of patients scheduled for conservative treatment avoided operation during the follow-up period. Patients in need of primary or secondary surgery were younger than patients receiving continued conservative treatment.
This was a study where patient data arose from an audit of records from a large cohort of patients with rectosigmoid endometriosis. Retrospective designs are prone to bias and results should be interpreted with caution. Information regarding medical treatment can be difficult to identify, as reflected by the number of missing values in the dataset. The study design also impaired collection of pain response to medical treatment, and analysis of type and severity of symptoms. However, all patients treated conservatively were seen at least once a year and examined with transvaginal ultrasonography and their clinical status was evaluated. Although we did not monitor these patients with VAS-score or regular questionnaires, these visits enabled us to monitor the clinical status of the patients. Longer follow up of this group would have given better information on the number of patients remaining stable without the need for surgery.
Strengths of the study included the size of the cohort and that patients received treatment in one center only. We found a significant difference in age between surgically and conservatively treated patients. Previous studies have indicated that younger patients with DIE have a higher risk of recurrence of pain after surgery than older patients (11, 12) . Cheong et al. (2008) found a higher risk of repeat surgery if the woman was less than 30 years of age (13) . Thus, young patients presenting with symptomatic rectosigmoid endometriosis may have more aggressive disease than patients diagnosed at a later age.
In our series, 33% of patients with rectosigmoid endometriosis were referred for primary surgery. Only 17% of women receiving primary conservative treatment needed referral to secondary surgery within the follow-up period. More than half (56%) of our patients with rectosigmoid endometriosis could thus be treated conservatively for a prolonged period. This supports a conservative approach to patients with DIE (14-16) rather than routine radical excision in cases without ureter or bowel obstruction.
Patients with rectosigmoid endometriosis should be thoroughly informed regarding the potential risks and benefits of surgical or medical treatment. Long-term medical treatment is typically offered to patients without a current wish to conceive, whereas the situation is more complex when pregnancy is the first priority in younger patients. Many of these patients will be directly referred for in vitro fertilization, but surgery may be an alternative, especially when pain is unacceptable to the patient.
Some authors suggest that surgery for rectosigmoid endometriosis might improve the outcome of in vitro fertilization (17, 18) , which could call for advising patients desiring to become pregnant to have such treatment performed. However, available evidence is still limited on this issue.
In our series, increasing pain was the main reason for secondary surgery, but three patients also had de novo obstruction of bowel or ureter, without such pathology at the initial MRI. These complications developed during in vitro fertilization treatment. More data are needed on the incidence of these problems during continued conservative treatment, but in vitro fertilization seems to represent a risk factor (19, 20) .
Overall, patients with DIE should be followed due to the risk of progression and the complexity of the disease. The need for thorough investigation and counseling suggests that these patients are followed in a tertiary referral center (21) .
No differences emerged in MRI findings between surgically and conservatively treated patients. Thus, the occurrence of adenomyosis, multiple nodules, retrocervical location and distance to the anal verge were similar. Neither did we find any difference in the distribution of endometriomas, which was seen in 48% of our patients with rectosigmoid endometriosis, in agreement with Roman et al. (22) . In contrast, Chapron et al. found endometriomas in 23% in patient with DIE, but their study included patients without rectosigmoid disease (23, 24) .
Taken together, we found no evidence in the present study that the phenotype of DIE found at MRI can predict future response to medical treatment or the need for surgery. Other aspects may be important, such as the individual predisposition to local growth of sensory autonomous nerves induced by the endometriotic tissue (25) . Thus, patients with pain might represent an as yet undefined genetic subtype of endometriosis.
Prospective studies incorporating systematic monitoring of pain symptoms and quality of life during conservative treatment for rectosigmoid endometriosis are needed.
Conclusions
More than 80% of patients, referred to a tertiary referral center with rectosigmoid endometriosis and initially scheduled for conservative treatment, seemed to respond favorably to this treatment, thus avoiding major surgery and associated complications. Young age at referral was a predictor of the need for surgical treatment.
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